Product NDC: | 0149-0471 |
Proprietary Name: | ACTONEL |
Non Proprietary Name: | RISEDRONATE SODIUM |
Active Ingredient(s): | 5 mg/1 & nbsp; RISEDRONATE SODIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0149-0471 |
Labeler Name: | Warner Chilcott Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020835 |
Marketing Category: | NDA |
Start Marketing Date: | 20000414 |
Package NDC: | 0149-0471-01 |
Package Description: | 12 BOTTLE in 1 CASE (0149-0471-01) > 30 TABLET, FILM COATED in 1 BOTTLE |
NDC Code | 0149-0471-01 |
Proprietary Name | ACTONEL |
Package Description | 12 BOTTLE in 1 CASE (0149-0471-01) > 30 TABLET, FILM COATED in 1 BOTTLE |
Product NDC | 0149-0471 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | RISEDRONATE SODIUM |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20000414 |
Marketing Category Name | NDA |
Labeler Name | Warner Chilcott Pharmaceuticals Inc. |
Substance Name | RISEDRONATE SODIUM |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |